Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Solon Eiendom ASA - Primary insider notification


Posted on: 10 Sep 18

(Oslo, Norway, September 07, 2018) Solon Eiendom ASA Chairman of the Board Simen Thorsen has today through his wholly owned company Hortulan AS acquired 5,650 shares in Solon Eiendom ASA at a price of NOK 29.0211 per share.

Following this transaction Simen Thorsen holds 4,000,000 shares privately and 11,261,248 shares through Hortulan AS, equaling 27.00 % of the total share capital and votes of the Company.

This information is subject to the disclosure requirements set out in section 5-12 of the Norwegian Securities Trading Act.
Further information
Andreas Martinussen
Chief Executive Officer, Solon Eiendom ASA
E-mail: am@soloneiendom.no Cell Phone: +47 400 00 405

Scott Danielsen
Chief Financial Officer, Solon Eiendom ASA
E-mail: sd@soloneiendom.no Cell Phone: +47 952 55 620

About Solon Eiendom
Solon Eiendom is a Norwegian residential real estate development company focusing on the Oslo and Akershus region.

Attachment

GlobeNewswire
globenewswire.com

Last updated on: 10/09/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.